Steven Visuri Email & Phone Number

Madison, Wisconsin, Us

Stem Pharm is a drug discovery company, leveraging a unique stem cell derived neural organoid platform for CNS disease modeling and drug screening. This platform can provide insights across a wide spectrum of neuroinflammatory-related diseases including neurodegenerative diseases and brain cancers. Stem Pharm's biomaterials have advantages to many cell and tissue culture applications including cell therapy, regenerative medicine and personalized medicine diagnostics.

Angel Investment Network (100+ members).Golden Angels Investors, LLC (GAI) invests in early-stage companies across a range of industries. We are interested in helping new ventures grow and succeed from early stages to growth and success.This assistance includes investment, but beyond equity capital, members contribute expertise and connections to help strengthen company success.

Developed concept for novel probiotic for sinus health, licensed foundational IP, and established regulatory path to market.

Led the founding, strategy, organization, financing, and product development of a start-up medical therapeutic company focused on leveraging the gut microbiome to treat gastrointestinal disorders. FloraSeq was focused on C. difficile infection and successfully advanced a lyophilized live biotherapeutic drug to clinical studies with >80% success rate.

Ca, 92121, Us

Responsible for development and commercialization of molecular (PCR-based) in vitro diagnostic assays for infectious diseases and support of business activities.Site lead for Prodesse business unit with responsibility for R&D, marketing, quality, clinical, regulatory, and intellectual property. Accountability to corporate executive staff, develop and execute business strategies, grow value of business unit through development of new products and markets and identification of strategic partners.Accomplishments include:Development and FDA clearance of several respiratory and gastrointestinal assays.Initiated significant development effort for next generation automated diagnostic platform: subsequently directed assay development team and was marketing core team lead for instrument and assays.Developed transition plans for migrating current product line.Directed site closure of Waukesha facility and transfer/consolidation of activities to diagnostic center in San Diego as cost saving measure.Managed budgets with no cost overruns for five years.

Broad responsibilities in R&D, Regulatory, Clinical, Quality, and Intellectual Property.Instrumental in the acquisition of Prodesse by Gen-Probe for >$72M.Primary responsibility was to grow the value of the company via internal development, building collaborations, and commercialization of in vitro diagnostic assays for infectious diseases.Accomplishments include:Led R&D team in development of 7 FDA cleared molecular diagnostic IVD's for the detection of respiratory and gastrointestinal pathogens.Instituted Design Control System compliant with ISO 13485 and FDA.Initiated collaborations with emerging and industry leading biotechnology companies.Provided strategic direction and technology assessment.Reviewed and provided guidance on intellectual property and licensing.

Livermore, Ca, Us

Responsible for development of innovative medical devices (therapeutics and diagnostics) including specialization in optics and microfluidics, initiating original research projects, obtaining funding, marketing technologies, and supervising employees.Procured >$15M in development funds.Inventor on nine patents, six of which were licensed by industry.Supervised group of 20+ scientists, engineers, and technicians.Focus areas for R&D included:Pathogen Detection (in vitro diagnostics) - immunologic and nucleic acid assaysMicrofluidic Circuits and ComponentsDrug Delivery & Gene TransferTherapeutic AcousticsPhotodynamic Cancer TherapyGeneral Medical Laser Applications

Phd, Biomedical Engineering

Bs, Electrical Engineering